Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

BC Craft Supply Co Ltd (CSE:CRFT) is a diversified life sciences company advancing cannabinoid and psychedelic innovation and psychotherapy.  The Company offers a reimagined vision for craft markets through collaboration, expertise, and adaptation. 

It’s operations include CRFT - a curator and aggregator of craft cannabis, providing advocacy and access for premium small-batch growers to Canada’s cannabis market; Medcann Health Products - a cultivation and processing facility in Chemainus providing access to both Canadian medical and recreational cannabis markets; Feelwell Brands - a successful cannabinoid brand house licensed in the state of California; and AVA Pathways - a pre-clinical biotech company focused on neuroplasticity and mental health applications using psilocybin and compounds derived from mushrooms.

The Issuer is an United States multi-state cannabis CPG company that reaches over 113 million Americans across California, Colorado, Florida, Illinois, Maryland, Nevada, Michigan and Oklahoma, with a portfolio of cannabis brands.

Better Plant provides marketing, financial, branding, bookkeeping and other services. Better Plant is currently halted pursuant to a reverse merger transaction as announced on February 15, 2022 and on April 26, 2022.

BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.

BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non-controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife’s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder and other neuro-psychiatric and neurological disorders.

BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency.

BetterLife also owns a drug candidate for the treatment of viral infections such as COVID-19 and is in the process of seeking strategic alternatives for further development.

bettermoo(d) Food Corporation is an innovative beverage company focused on delivering high quality products through online and in-store retail platforms. bettermoo(d) Food Corporation utilizes social media to deliver educational experiences for their customer base while demonstrating - pioneering beverage technologies.

bettermoo(d) Food Corporation's wholly owned subsidiary Happy Tea provides high-quality CBD beverages developed to assist in alleviating stress, decreasing anxiety and minimizing inflammation to support enhanced daily routines. For more information on Happy Tea and to find products near you, please visit www.happytea.com.

bettermoo(d) Food Corporation's other wholly owned subsidiary, bettermoo(d), is a purpose driven plant-based, alternative dairy brand based in Vancouver, British Columbia, Canada, driven by the motto, “What A Cow Eats and A Human Needs”. Inspired by rich and creamy milks and cheeses from the Alps regions of Europe, bettermoo(d) dairy alternatives are infused with a proprietary blend of herbs, similar to those eaten by pasture-raised cows in these regions, prior to the introduction of mass factory farming of cows for milk. Launching spring 2022, bettermoo(d)’s first product, Moodrink, will be available for purchase across Canada. For more information on bettermoo(d) and to find products near you, please visit www.bettermoo.com.

BevCanna Enterprises Inc. seeks to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles. BevCanna’s vision is to be the global leader infused innovations.

Make the fairly enjoyable ridiculously fun! For over a decade, Bhang has delivered exceptional sensory experiences to consumers through its extensive portfolio of over 50 master-chef created cannabis, CBD, and terpene products including highly-awarded gourmet chocolates, pre-rolls, CBD isolate, and Hempsticks™. Bhang’s gourmet, cannabis-infused chocolates are among the top-selling edibles in 7 U.S. states and Canada. Bhang’s CBD products are globally-distributed and known for being safe, efficacious and delicious. 

Investor Note: In addition to the 107,358,457 Subordinate Voting Shares that are listed and trading, there are 47,292,501 Subordinate Voting Shares reserved for issuance pursuant to the conversion rights attached to other classes of equity shares that are issued and outstanding but not listed. The total number of issued shares assuming all equity shares are converted into the listed class would be 154,650,958.

 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

BioHarvest Sciences has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets.

BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology platform leverages "Omics" and machine learning which allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection solution to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-12-07-Arcview-Access-Cannabis-Investment-Summit_Website.jpg

Arcview Access Cannabis Investment Summit

Wednesday, December 7, 2022 - 7:00pm to Friday, December 9, 2022 - 1:00pm

Advertisement

Publicité